Analysis

Glucotrack, Inc. Executes 20-for-1 Reverse Stock Split and Announces Public Offering

02/04/2025

News

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology

02/26/2025

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Rutherford, NJ., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the pricing of a “best efforts” public offering of approximately 2.6 million shares of common stock. The offering price of each share of common stock is $1.15, The gross proceeds of the public offering are expected to be approximately $3.0 million before deducting agent placement fees and offering expenses. The closing of the public offering is expected to occur on or about February 5, 2025, subject to the satisfaction of customary closing conditions.

02/04/2025

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is GlucoTrack, Inc. (GCTK) a buy, sell, or hold?

GlucoTrack, Inc. (GCTK) can sell. Click on Rating Page for detail.

What is GlucoTrack, Inc.'s stock price?

The price of GlucoTrack, Inc. (GCTK) is 0.356 and it was updated on 2025-03-12 11:00:13.

Is GlucoTrack, Inc. (GCTK) overvalued or undervalued?

Currently GlucoTrack, Inc. (GCTK) is in undervalued.

News

From:

To:

News
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor The study met its primary endpoint with no procedure or device related serious adverse events reported The study met its primary endpoint with no procedure or device related serious adverse events reported Tue, Feb. 04, 2025
Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer Industry veteran Peter C. Wulff joins Glucotrack to drive financial strategy and commercialization of its continuous blood glucose monitor for people with diabetes Industry veteran Peter C. Wulff joins Glucotrack to drive financial strategy and commercialization of its continuous blood glucose monitor for people with diabetes Wed, Jan. 29, 2025
Glucotrack Announces ISO 13485:2016 Certification ISO Certification highlights commitment to quality for continuous blood glucose monitor ISO Certification highlights commitment to quality for continuous blood glucose monitor Tue, Jan. 21, 2025
Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs New hire set to drive clinical development and U.S. commercialization of the continuous blood glucose monitor for people with diabetes New hire set to drive clinical development and U.S. commercialization of the continuous blood glucose monitor for people with diabetes Wed, Jan. 15, 2025
Glucotrack to Present at TechBio Showcase™ 2025 Presentation to feature an update on the Company's novel continuous blood glucose monitor for patients with diabetes Presentation to feature an update on the Company's novel continuous blood glucose monitor for patients with diabetes Tue, Jan. 07, 2025

SEC Filings

SEC Filings
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 02/26/2025
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 02/14/2025
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 02/07/2025
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 02/05/2025
GlucoTrack, Inc. (GCTK) - 424B5 SEC Filings 02/05/2025
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 02/04/2025
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/30/2025
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/29/2025
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/21/2025
GlucoTrack, Inc. (GCTK) - 8-K/A - Current report SEC Filings 01/14/2025
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/13/2025
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/08/2025
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/07/2025
GlucoTrack, Inc. (GCTK) - SCHEDULE 13G/A SEC Filings 01/03/2025
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 12/31/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 12/17/2024
GlucoTrack, Inc. (GCTK) - 424B5 SEC Filings 12/17/2024
GlucoTrack, Inc. (GCTK) - DEF 14A SEC Filings 12/06/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 12/03/2024
GlucoTrack, Inc. (GCTK) - PRE 14A SEC Filings 11/22/2024
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 11/22/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/18/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/14/2024
GlucoTrack, Inc. (GCTK) - 424B4 SEC Filings 11/14/2024
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/14/2024
GlucoTrack, Inc. (GCTK) - EFFECT SEC Filings 11/13/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/13/2024
GlucoTrack, Inc. (GCTK) - S-1/A SEC Filings 11/08/2024
GlucoTrack, Inc. (GCTK) - S-1/A SEC Filings 11/04/2024
GlucoTrack, Inc. (GCTK) - S-1/A SEC Filings 10/24/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/22/2024
GlucoTrack, Inc. (GCTK) - EFFECT SEC Filings 10/04/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/01/2024
GlucoTrack, Inc. (GCTK) - S-3/A SEC Filings 09/30/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 09/26/2024
GlucoTrack, Inc. (GCTK) - S-3 SEC Filings 09/23/2024
GlucoTrack, Inc. (GCTK) - S-1 SEC Filings 09/16/2024
GlucoTrack, Inc. (GCTK) - SC 13G SEC Filings 09/10/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 09/10/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 09/03/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 08/27/2024
GlucoTrack, Inc. (GCTK) - S-8 SEC Filings 08/19/2024
GlucoTrack, Inc. (GCTK) - DEF 14A SEC Filings 08/19/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 08/15/2024
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/13/2024
GlucoTrack, Inc. (GCTK) - PRE 14A SEC Filings 08/09/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 08/05/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 07/31/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 07/22/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 07/08/2024
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 07/03/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 07/01/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 06/20/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 06/13/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 05/24/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 05/20/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 05/16/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 05/15/2024
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/15/2024
GlucoTrack, Inc. (GCTK) - D SEC Filings 05/08/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 05/02/2024
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 04/24/2024
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 04/24/2024
GlucoTrack, Inc. (GCTK) - DEF 14A SEC Filings 04/01/2024
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 03/28/2024
GlucoTrack, Inc. (GCTK) - PRE 14A SEC Filings 03/22/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 02/16/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/11/2024
GlucoTrack, Inc. (GCTK) - SC 13G SEC Filings 01/03/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/02/2024
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/30/2023
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/14/2023
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 10/18/2023
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/13/2023
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/12/2023
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 09/11/2023
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 08/31/2023
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/14/2023
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 06/02/2023
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 05/19/2023
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/12/2023
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 04/17/2023
GlucoTrack, Inc. (GCTK) - 424B5 SEC Filings 04/17/2023
GlucoTrack, Inc. (GCTK) - 424B5 SEC Filings 04/13/2023
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 04/06/2023
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 03/31/2023
GlucoTrack, Inc. (GCTK) - DEF 14A SEC Filings 03/02/2023
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 02/13/2023
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/10/2023
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/25/2022
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/14/2022
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/15/2022
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 08/10/2022
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/16/2022
GlucoTrack, Inc. (GCTK) - 10-K/A - Current report SEC Filings 04/29/2022
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 03/31/2022
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/28/2022
GlucoTrack, Inc. (GCTK) - CERT SEC Filings 12/09/2021
GlucoTrack, Inc. (GCTK) - 8-A12B SEC Filings 12/08/2021
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/15/2021
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/25/2021
GlucoTrack, Inc. (GCTK) - EFFECT SEC Filings 09/28/2021
GlucoTrack, Inc. (GCTK) - EFFECT SEC Filings 09/27/2021
GlucoTrack, Inc. (GCTK) - UPLOAD SEC Filings 09/23/2021
GlucoTrack, Inc. (GCTK) - CORRESP SEC Filings 09/23/2021
GlucoTrack, Inc. (GCTK) - S-3 SEC Filings 09/20/2021
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/16/2021
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 06/29/2021
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/21/2021
GlucoTrack, Inc. (GCTK) - NT 10-Q - Quarterly Report SEC Filings 05/17/2021
GlucoTrack, Inc. (GCTK) - 10-K/A - Current report SEC Filings 04/30/2021
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 04/13/2021
GlucoTrack, Inc. (GCTK) - NT 10-K - Current report SEC Filings 03/31/2021
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 02/08/2021
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 12/22/2020
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/16/2020
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/12/2020
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/08/2020
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/14/2020
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/19/2020
GlucoTrack, Inc. (GCTK) - NT 10-Q - Quarterly Report SEC Filings 05/13/2020
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 04/23/2020
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 04/14/2020
GlucoTrack, Inc. (GCTK) - NT 10-K - Current report SEC Filings 03/30/2020
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/30/2020
GlucoTrack, Inc. (GCTK) - D SEC Filings 02/28/2020
GlucoTrack, Inc. (GCTK) - DEF 14A SEC Filings 02/26/2020
GlucoTrack, Inc. (GCTK) - SC 13D SEC Filings 02/25/2020
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 02/21/2020
GlucoTrack, Inc. (GCTK) - PRE 14A SEC Filings 02/11/2020
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/26/2019
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/13/2019
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/06/2019
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/31/2019
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 09/04/2019
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 08/14/2019
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/14/2019
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 08/08/2019
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 08/05/2019
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 07/19/2019
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 07/12/2019
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 06/20/2019
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/15/2019
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 04/15/2019
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 04/01/2019
GlucoTrack, Inc. (GCTK) - NT 10-K - Current report SEC Filings 03/29/2019
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/07/2019
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 12/26/2018
GlucoTrack, Inc. (GCTK) - DEF 14A SEC Filings 11/23/2018
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/14/2018
GlucoTrack, Inc. (GCTK) - PRE 14A SEC Filings 11/13/2018
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/09/2018
GlucoTrack, Inc. (GCTK) - 424B3 SEC Filings 08/20/2018
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/14/2018
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 07/25/2018
GlucoTrack, Inc. (GCTK) - EFFECT SEC Filings 07/02/2018
GlucoTrack, Inc. (GCTK) - 424B3 SEC Filings 07/02/2018
GlucoTrack, Inc. (GCTK) - POS AM SEC Filings 06/07/2018
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/15/2018
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 03/30/2018
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/23/2018
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/07/2018
GlucoTrack, Inc. (GCTK) - DEFA14A SEC Filings 03/06/2018
GlucoTrack, Inc. (GCTK) - DEFR14A SEC Filings 03/02/2018
GlucoTrack, Inc. (GCTK) - DEF 14A SEC Filings 03/01/2018
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 12/28/2017
GlucoTrack, Inc. (GCTK) - EFFECT SEC Filings 12/27/2017
GlucoTrack, Inc. (GCTK) - S-1/A SEC Filings 12/21/2017
GlucoTrack, Inc. (GCTK) - CORRESP SEC Filings 12/21/2017
GlucoTrack, Inc. (GCTK) - D SEC Filings 12/11/2017
GlucoTrack, Inc. (GCTK) - S-1/A SEC Filings 12/08/2017
GlucoTrack, Inc. (GCTK) - CORRESP SEC Filings 12/08/2017
GlucoTrack, Inc. (GCTK) - UPLOAD SEC Filings 11/29/2017
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/14/2017
GlucoTrack, Inc. (GCTK) - S-1 SEC Filings 11/07/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/03/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/01/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/23/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/05/2017
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/14/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 08/02/2017
GlucoTrack, Inc. (GCTK) - D/A SEC Filings 06/28/2017
GlucoTrack, Inc. (GCTK) - 8-K/A - Current report SEC Filings 06/28/2017
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 06/28/2017
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 06/28/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 06/23/2017
GlucoTrack, Inc. (GCTK) - 4/A SEC Filings 06/09/2017
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 06/09/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 06/08/2017
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 06/08/2017
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 06/07/2017
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 06/06/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 05/30/2017
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/15/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 05/10/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 05/03/2017
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 04/14/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 04/13/2017
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 03/31/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/30/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/24/2017
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 03/22/2017
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 03/22/2017
GlucoTrack, Inc. (GCTK) - SC 13G SEC Filings 03/20/2017
GlucoTrack, Inc. (GCTK) - SC 13D/A SEC Filings 03/15/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/14/2017
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 03/14/2017
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 02/09/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 02/06/2017
GlucoTrack, Inc. (GCTK) - D/A SEC Filings 01/20/2017
GlucoTrack, Inc. (GCTK) - SC 13D SEC Filings 01/13/2017
GlucoTrack, Inc. (GCTK) - 3/A SEC Filings 01/13/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/09/2017
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 12/05/2016
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 12/02/2016
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 11/21/2016
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 11/21/2016
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/16/2016
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 11/15/2016
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 11/15/2016
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/14/2016
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/07/2016
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 09/07/2016
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/15/2016
GlucoTrack, Inc. (GCTK) - EFFECT SEC Filings 07/19/2016
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 07/07/2016
GlucoTrack, Inc. (GCTK) - POS AM SEC Filings 06/22/2016
GlucoTrack, Inc. (GCTK) - S-8 SEC Filings 06/15/2016
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 06/06/2016
GlucoTrack, Inc. (GCTK) - SD SEC Filings 05/31/2016
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/16/2016
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 05/04/2016
GlucoTrack, Inc. (GCTK) - 10-K/A - Current report SEC Filings 04/29/2016
GlucoTrack, Inc. (GCTK) - D SEC Filings 04/18/2016
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 04/14/2016
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 03/30/2016
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 03/25/2016
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 03/25/2016
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/23/2016
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 03/21/2016
GlucoTrack, Inc. (GCTK) - SC 13G/A SEC Filings 02/16/2016
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 02/10/2016
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 01/11/2016
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/16/2015
GlucoTrack, Inc. (GCTK) - S-8 SEC Filings 09/21/2015
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/14/2015
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 07/31/2015
GlucoTrack, Inc. (GCTK) - DEFA14A SEC Filings 07/22/2015
GlucoTrack, Inc. (GCTK) - DEFA14A SEC Filings 06/05/2015
GlucoTrack, Inc. (GCTK) - SD SEC Filings 06/01/2015
GlucoTrack, Inc. (GCTK) - 424B3 SEC Filings 05/19/2015
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/15/2015
GlucoTrack, Inc. (GCTK) - DEF 14A SEC Filings 04/30/2015
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 04/30/2015
GlucoTrack, Inc. (GCTK) - 424B3 SEC Filings 04/22/2015
GlucoTrack, Inc. (GCTK) - EFFECT SEC Filings 04/16/2015
GlucoTrack, Inc. (GCTK) - S-1 SEC Filings 03/31/2015
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 03/31/2015
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/13/2015
GlucoTrack, Inc. (GCTK) - 4 SEC Filings 03/13/2015
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 12/31/2014
GlucoTrack, Inc. (GCTK) - 424B3 SEC Filings 11/20/2014
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/14/2014
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/06/2014
GlucoTrack, Inc. (GCTK) - 424B3 SEC Filings 10/16/2014
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/06/2014
GlucoTrack, Inc. (GCTK) - D SEC Filings 09/12/2014
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 09/05/2014
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/19/2014
GlucoTrack, Inc. (GCTK) - NT 10-Q - Quarterly Report SEC Filings 08/14/2014
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 07/24/2014
GlucoTrack, Inc. (GCTK) - DEFA14A SEC Filings 07/09/2014
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 05/27/2014
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/13/2014
GlucoTrack, Inc. (GCTK) - EFFECT SEC Filings 05/05/2014
GlucoTrack, Inc. (GCTK) - DEFA14A SEC Filings 05/05/2014
GlucoTrack, Inc. (GCTK) - 424B3 SEC Filings 05/05/2014
GlucoTrack, Inc. (GCTK) - DEF 14A SEC Filings 04/30/2014
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 04/29/2014
GlucoTrack, Inc. (GCTK) - POS AM SEC Filings 03/28/2014
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 03/28/2014
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/17/2014
GlucoTrack, Inc. (GCTK) - SC 13G/A SEC Filings 02/12/2014
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/14/2013
GlucoTrack, Inc. (GCTK) - 8-K/A - Current report SEC Filings 11/07/2013
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/29/2013
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 10/28/2013
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/19/2013
GlucoTrack, Inc. (GCTK) - NT 10-Q - Quarterly Report SEC Filings 08/15/2013
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 06/20/2013
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 06/04/2013
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/20/2013
GlucoTrack, Inc. (GCTK) - NT 10-Q - Quarterly Report SEC Filings 05/16/2013
GlucoTrack, Inc. (GCTK) - EFFECT SEC Filings 05/15/2013
GlucoTrack, Inc. (GCTK) - 424B3 SEC Filings 05/15/2013
GlucoTrack, Inc. (GCTK) - S-1/A SEC Filings 05/14/2013
GlucoTrack, Inc. (GCTK) - S-1/A SEC Filings 05/13/2013
GlucoTrack, Inc. (GCTK) - DEF 14A SEC Filings 04/30/2013
GlucoTrack, Inc. (GCTK) - S-1 SEC Filings 04/29/2013
GlucoTrack, Inc. (GCTK) - ARS SEC Filings 04/29/2013
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 04/09/2013
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 04/01/2013
GlucoTrack, Inc. (GCTK) - D/A SEC Filings 03/28/2013
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/18/2013
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 03/12/2013
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 03/06/2013
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 02/28/2013
GlucoTrack, Inc. (GCTK) - SC 13G SEC Filings 02/14/2013
GlucoTrack, Inc. (GCTK) - RW SEC Filings 01/16/2013
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 12/19/2012
GlucoTrack, Inc. (GCTK) - D SEC Filings 12/03/2012
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 11/19/2012
GlucoTrack, Inc. (GCTK) - NT 10-Q - Quarterly Report SEC Filings 11/15/2012
GlucoTrack, Inc. (GCTK) - 8-K - Current report SEC Filings 11/08/2012
GlucoTrack, Inc. (GCTK) - POS AM SEC Filings 09/28/2012
GlucoTrack, Inc. (GCTK) - 10-Q/A - Quarterly Report SEC Filings 09/12/2012
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 08/28/2012
GlucoTrack, Inc. (GCTK) - 3 SEC Filings 08/24/2012
GlucoTrack, Inc. (GCTK) - 8-A12G SEC Filings 08/14/2012
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 08/14/2012
GlucoTrack, Inc. (GCTK) - 10-K/A - Current report SEC Filings 08/14/2012
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 05/15/2012
GlucoTrack, Inc. (GCTK) - 10-K - Current report SEC Filings 03/14/2012
GlucoTrack, Inc. (GCTK) - 10-Q/A - Quarterly Report SEC Filings 01/27/2012
GlucoTrack, Inc. (GCTK) - 10-Q - Quarterly Report SEC Filings 12/29/2011
GlucoTrack, Inc. (GCTK) - EFFECT SEC Filings 11/15/2011
GlucoTrack, Inc. (GCTK) - UPLOAD SEC Filings 11/10/2011
GlucoTrack, Inc. (GCTK) - S-1/A SEC Filings 11/10/2011
GlucoTrack, Inc. (GCTK) - CORRESP SEC Filings 11/10/2011
GlucoTrack, Inc. (GCTK) - S-1/A SEC Filings 10/27/2011
GlucoTrack, Inc. (GCTK) - CORRESP SEC Filings 10/26/2011
GlucoTrack, Inc. (GCTK) - UPLOAD SEC Filings 10/24/2011
GlucoTrack, Inc. (GCTK) - S-1/A SEC Filings 10/07/2011
GlucoTrack, Inc. (GCTK) - CORRESP SEC Filings 10/07/2011
GlucoTrack, Inc. (GCTK) - UPLOAD SEC Filings 09/16/2011
GlucoTrack, Inc. (GCTK) - S-1 SEC Filings 08/22/2011
GlucoTrack, Inc. (GCTK) - D SEC Filings 12/27/2010

Press Releases

StockPrice Release
Glucotrack appoints guillermo umpierrez, md, cdces, face, macp as new medical advisory board member 02/26/2025
Glucotrack, inc. announces pricing of $3.0 million public offering 02/04/2025
Glucotrack announces successful completion of its first human clinical study of continuous blood glucose monitor 02/04/2025
Glucotrack strengthens leadership team with appointment of new chief financial officer 01/29/2025
Glucotrack announces iso 13485:2016 certification 01/21/2025
Glucotrack strenghtens leadership team with addition of industry veteran as vice president of regulatory affairs 01/15/2025
Glucotrack to present at techbio showcase™ 2025 01/07/2025
Glucotrack announces start of enrollment for human clinical study of continuous blood glucose monitor 12/03/2024
Glucotrack, inc. announces closing of $10.0 million public offering and concurrent private placement converting $4.0 in outstanding debt 11/14/2024
Glucotrack to present at 2024 biofuture conference 10/22/2024
Glucotrack announces oral & poster presentations at the 2024 diabetes technology meeting 10/01/2024
John ballantyne, former biotechnology executive, joins the glucotrack board of directors 09/03/2024
Glucotrack's innovative blood glucose monitoring concept resonates with patients with diabetes, according to new survey presented at association of diabetes care and education specialists (adces) 2024 annual conference 08/15/2024
Glucotrack announces poster presentation on continuous blood glucose monitor survey data at the association of diabetes care and education specialists (adces) 2024 annual conference 08/05/2024
Glucotrack announces the appointment of andy balo to board of directors 06/20/2024
Glucotrack reports successful completion of first reported long-term preclinical study of its epidural glucose monitoring sensor 06/13/2024
Glucotrack to present in the june 2024 sidoti small cap conference 06/10/2024
Glucotrack announces 90-day preclinical study results that demonstrate sustained accuracy of its implantable continuous blood glucose monitor 06/05/2024
Glucotrack's epidural glucose monitoring sensor demonstrates successful 30-day safety & performance in long-term preclinical study 05/16/2024
Glucotrack announces reverse stock split 05/15/2024
Glucotrack announces abstracts accepted for poster presentation at 84th scientific sessions of the american diabetes association 05/02/2024
Glucotrack announces closing of private placement 04/22/2024
Glucotrack announces expansion of its continuous glucose monitoring technology to epidural glucose monitoring 04/16/2024
Glucotrack announces increased sensor longevity for its implantable continuous blood glucose monitor 04/02/2024
Glucotrack expands leadership team with new vice president of quality 03/12/2024
Glucotrack selects cirtec medical as manufacturer for its implantable continuous blood glucose monitor 02/27/2024
Glucotrack announces the appointment of luis malavÉ to chair of the board of directors 02/13/2024
Glucotrack announces early accuracy data for its implantable continuous glucose monitor 01/02/2024
Glucotrack announces 180-day extension to regain compliance with nasdaq minimum bid price requirement 11/30/2023
Glucotrack announces shareholder update 11/13/2023
Glucotrack announces preclinical testing with implantable continuous glucose monitor 10/12/2023
Glucotrack announces the appointment of erin carter to board of directors 08/31/2023
Glucotrack announces new vp of marketing 08/28/2023
Glucotrack announces positive data from feasibility study for implantable continuous glucose monitor 07/25/2023
Aegis capital corp. acted as sole bookrunner on a $10 million underwritten public offering for glucotrack, inc. (nasdaq: gctk) 04/17/2023
Glucotrack closes $10 million underwritten public offering of common stock 04/17/2023
Glucotrack announces pricing of $10 million underwritten public offering of common stock 04/13/2023
Glucotrack announces proposed underwritten public offering of common stock 04/12/2023
Glucotrack provides shareholder update 03/14/2023
Glucotrack announces the hiring of dr. mark tapsak 10/14/2022
Glucotrack announces the hiring of dr. mark tapsak 10/14/2022
Glucotrack to begin research & development of novel continuous glucose monitoring system 10/10/2022
Glucotrack, inc. provides development update on its gen 2 non-invasive glucose monitor 06/22/2022
Glucotrack, inc. announces effectiveness of corporate name change and ticker symbol change 03/14/2022

More Headlines

News
GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR Feasibility study underway for the Company's novel continuous blood glucose monitor in patients with diabetes, with data expected within 6-8 weeks 12/03/2024
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt Rutherford, NJ., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the closing of a “best efforts” public offering of 2,437,340 shares of common stock and 4,756,900 pre-funded warrants, with each share of common stock and each pre-funded warrant accompanied by (i) a series A common warrant to purchase one (1) share of common stock at an exercise price of $1.81 per share and (ii) a series B common warrant to purchase one (1) share of common stock at an exercise price of $1.81 per share. The combined offering price of each share of common stock together with the accompanying series A and series B common warrants is $1.39, and the combined offering price of each pre-funded warrant together with the accompanying series A and series B common warrants is $1.389. The gross proceeds of the public offering were approximately $10 million before deducting placement agent fees and offering expenses. 11/14/2024
GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE Continuous blood glucose monitor to be among 100+ future-focused presentations at industry investor conference Rutherford, NJ, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will participate in the 2024 BioFuture Conference, to be held at Cure in New York City from October 28-30, 2024. Paul V. Goode, President & Chief Executive Officer of Glucotrack, will present on Tuesday, October 29, 2024, at 11:00 AM ET and will hold one-on-one meetings. 10/22/2024
GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING Updated preclinical data for the continuous blood glucose monitor to be presented at major diabetes technology conference 10/01/2024
JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS Biotech veteran joins Glucotrack's Board to support bringing novel continuous blood glucose monitoring technology to people with diabetes 09/03/2024
Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference Glucotrack ADCES poster highlights over 50% of surveyed diabetes patients are open to new Continuous Blood Glucose Monitor concept 08/15/2024
GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE Market research data shows interest in additional glucose monitoring options for people with diabetes who use insulin Rutherford, NJ, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that an emerging science industry poster will be presented at the Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference to be held August 9-12, 2024 in New Orleans, LA. The Glucotrack poster will present market research data on the acceptance of the Company's Continuous Blood Glucose Monitor (CBGM) concept among people with type 1 and type 2 diabetes. 08/05/2024
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS Diabetes industry veteran joins Glucotrack's Board to support bringing novel continuous blood glucose monitoring technology to people with diabetes 06/20/2024
GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR Completion of the novel epidural continuous glucose monitoring study confirms its potential for providing simplified disease management for patients with painful diabetic neuropathy 06/13/2024
GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE Rutherford, NJ, June 10, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will participate in the Sidoti Small Cap Investor Conference. 06/10/2024
GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR Highly accurate continuous blood glucose monitor demonstrates Mean Absolute Relative Difference (MARD) of 4.7% at Day 90 06/05/2024
GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY Promising results support the potential of epidural glucose monitoring for simplified disease management for patients with painful diabetic neuropathy 05/16/2024
GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT 1-for-5 reverse stock split to become effective as of the opening of trading on May 20, 2024 Rutherford, NJ, May 15, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will effect a 1-for-5 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding common stock (the “Common Stock”), effective with the opening of trading on Monday, May 20, 2024. Glucotrack's Common Stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “GCTK”. 05/15/2024
GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION Continuous blood glucose monitor's preclinical data and sensor longevity modeling to be presented at major diabetes conference 05/02/2024
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT Rutherford, NJ, April 22, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that the Company has closed a private placement of securities. The Offering included participation by CEO Paul V. Goode, PhD, as well as other members of the Company's executive management, Board of Directors, and existing shareholders. 04/22/2024
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING Expansion offers the potential for continuous, discreet and simplified epidural glucose monitoring solutions for patients with Painful Diabetic Neuropathy 04/16/2024
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR Computational modeling with The Technology Partnership shows sensor longevity beyond 3 years; 1 year longer than previously announced 04/02/2024
GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY Rutherford, NJ, March 12, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that Vincent Wong has joined the Company as Vice President of Quality. 03/12/2024
GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR Rutherford, NJ & Brooklyn Park, MN, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced the selection of Cirtec Medical Corp, the leading medical device solutions provider of implantable therapies, as manufacturer for the implantable Continuous Blood Glucose Monitor (CBGM). The two companies have signed a development agreement for clinical and commercial manufacturing. 02/27/2024
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS Rutherford, NJ, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes announced today that Luis Malavé has been elected as Chairman of its Board of Directors, effective immediately. 02/13/2024
GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR Rutherford, NJ, Jan. 02, 2024 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, provides, updates on initial and long-term preclinical testing for the implantable Continuous Blood Glucose Monitor™ (CBGM). 01/02/2024
GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT Rutherford, NJ, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today it has received a notification letter from Nasdaq Stock Market LLC (“Nasdaq”) that the Company has been granted an additional 180-day compliance period, or until May 20, 2024, to regain compliance with Nasdaq's minimum bid price rule. 11/30/2023
GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE Rutherford, NJ, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that Paul V. Goode, PhD, President and Chief Executive Officer has provided a shareholder update letter. 11/13/2023
GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR Rutherford, NJ, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has achieved another milestone in its development of an implantable continuous glucose monitor (CGM) by commencing preclinical animal testing. 10/12/2023
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS Rutherford, NJ, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has appointed Erin Carter to its Board of Directors and as Chair of its Audit Committee, effective immediately. 08/31/2023
GLUCOTRACK ANNOUNCES NEW VP OF MARKETING Rutherford, NJ, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that Drinda Benjamin has joined the company as Vice President of Marketing. 08/28/2023
GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR Rutherford, NJ, July 25, 2023 (GLOBE NEWSWIRE) -- - Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediabetes, announced today the completion and positive results of its feasibility study for its implantable continuous glucose monitor technology for patients with Type 1 and Type 2 insulin-dependent diabetes. 07/25/2023
Why Is GlucoTrack (GCTK) Stock Down 36% Today? GlucoTrack (NASDAQ: GCTK ) stock is falling on Thursday after the medical device company revealed plans for a proposed public stock offering. According to a news release from the company, it's planning for a firm commitment underwritten public offering. 04/13/2023
Spotting Winning Penny Stocks: 3 Top Tips Can these tips help you make money with penny stocks in 2023? The post Spotting Winning Penny Stocks: 3 Top Tips appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 04/11/2023

Unlock

GCTK Ratings Summary

GCTK Quant Ranking